Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development
Open Access
- 21 July 2020
- journal article
- research article
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 16 (9) , 2056-2071
Abstract
Invasive non-typhoidal Salmonella (iNTS) infections are a leading cause of bacteremia in Sub-Saharan Africa (sSA), thereby representing a major public health threat. Salmonella Typhimurium clade ST313 and Salmonella Enteriditis lineages associated with Western and Central/Eastern Africa are among the iNTS serovars which are of the greatest concern due to their case-fatality rate, especially in children and in the immunocompromised population. Identification of pathogen-associated features and host susceptibility factors that increase the risk for invasive non-typhoidal salmonellosis would be instrumental for the design of targeted prevention strategies, which are urgently needed given the increasing spread of multidrug-resistant iNTS in Africa. This review summarizes current knowledge of bacterial traits and host immune responses associated with iNTS infections in sSA, then discusses how this knowledge can guide vaccine development while providing a summary of vaccine candidates in preclinical and early clinical development.Keywords
This publication has 185 references indexed in Scilit:
- Sustained Protection in Mice Immunized with Fractional Doses of Salmonella Enteritidis Core and O Polysaccharide-Flagellin GlycoconjugatesPLOS ONE, 2013
- Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan AfricaNature Genetics, 2012
- Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in AfricaThe Lancet, 2012
- Malaria impairs resistance to Salmonella through heme- and heme oxygenase–dependent dysfunctional granulocyte mobilizationNature Medicine, 2011
- Reverse Vaccinology: Developing Vaccines in the Era of GenomicsImmunity, 2010
- Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidalSalmonellaby blood cells in AfricansProceedings of the National Academy of Sciences, 2010
- Primary immunodeficiencies: 2009 updateJournal of Allergy and Clinical Immunology, 2009
- Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case–control studyThe Lancet, 2009
- The porin OmpD from nontyphoidal Salmonella is a key target for a protective B1b cell antibody responseProceedings of the National Academy of Sciences, 2009
- Simian immunodeficiency virus–induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gutNature Medicine, 2008